Tested Applications
| Positive WB detected in | HEK-293T cells, HEK-293 cells, HeLa cells, Jurkat cells |
| Positive IF/ICC detected in | A431 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
15154-1-AP targets PSMB2 in WB, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag7198 Product name: Recombinant human PSMB2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-201 aa of BC000268 Sequence: MEYLIGIQGPDYVLVASDRVAASNIVQMKDDHDKMFKMSEKILLLCVGEAGDTVQFAEYIQKNVQLYKMRNGYELSPTAAANFTRRNLADCLRSRTPYHVNLLLAGYDEHEGPALYYMDYLAALAKAPFAAHGYGAFLTLSILDRYYTPTISRERAVELLRKCLEELQKRFILNLPTFSVRIIDKNGIHDLDNISFPKQGS Predict reactive species |
| Full Name | proteasome (prosome, macropain) subunit, beta type, 2 |
| Calculated Molecular Weight | 23 kDa |
| Observed Molecular Weight | 23 kDa |
| GenBank Accession Number | BC000268 |
| Gene Symbol | PSMB2 |
| Gene ID (NCBI) | 5690 |
| RRID | AB_2300322 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P49721 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
PSMB2, Proteasome subunit beta type-2, is also known as 20S proteasome subunit beta-4(PMID: 7918633). The proteasome is responsible for degradation of short lived and misfolded cytosolic and nuclear proteins in the cell and cleaves peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. PSMB2 is up-regulated in ovarian cancer cell lines. The up-regulation of PSMB2 may indicate the activated neuronal defensive mechanism in VAD (vitamin A depletion) brain regions (PMID: 21190828). Knockdown of PSMB2 suppresses hepatocellular carcinoma and gastric cancer cell proliferation and invasion (PMID: 29780166, PMID: 36110152).
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for PSMB2 antibody 15154-1-AP | Download protocol |
| WB protocol for PSMB2 antibody 15154-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The PSMB2 Polyclonal antibody (Cat# 15154-1-AP) has 9 citations across journals including Cell Reports Medicine, Phytomedicine, Oncogene, Cell & Molecular Neurobiology, PLoS Biology, Molecular Cancer Research, Frontiers in Pharmacology, Metabolic Brain Disease, and bioRxiv. Research fields span proteasome biology, oncology (Wilms tumor, cholangiocarcinoma, hepatocellular carcinoma, myeloma), neurodegeneration, immunoproteasome function, autophagy, and cardiac hypertrophy, with applications primarily in Western blot across human, mouse, and rat species.
| Species | Application | Title |
|---|---|---|
Cell Rep Med Suppressing proteasome activity enhances sensitivity to actinomycin D in diffuse anaplastic Wilms tumor | ||
Phytomedicine PTEN status determines therapeutic vulnerability to celastrol in cholangiocarcinoma | ||
Oncogene NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
| ||
Cell Mol Neurobiol Inhibition of the Proteasome Regulator PA28 Aggravates Oxidized Protein Overload in the Diabetic Rat Brain | ||
PLoS Biol Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits | ||
Mol Cancer Res Proteasome subunits differentially control Myeloma cell viability and proteasome inhibitor sensitivity. |













